BL
BLUE

Bleichroeder LP’s bluebird bio BLUE Stock Holding History

Bleichroeder LP’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-51,869
Closed -$1.02M – 75
2024
Q2 		$1.02M Hold
51,869
– – 0.3% 32
2024
Q1 		$1.33M Sell
51,869
-73,131
-59% -$1.87M 0.33% 26
2023
Q4 		$3.45M Buy
125,000
+80,000
+178% +$4.88M 0.77% 20
2023
Q3 		$2.74M Buy
+45,000
New +$3.16M 0.67% 22
2021
Q1 		– Sell
-1,930
Closed -$1.08M – 82
2020
Q4 		$1.08M Hold
1,930
– – 0.21% 40
2020
Q3 		$1.35M Hold
1,930
– – 0.24% 43
2020
Q2 		$1.53M Buy
+1,930
New +$1.46M 0.27% 41

Other funds holding BLUE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bleichroeder LP's BLUE Position: Q3 2024 in Review

Bleichroeder LP sold out of bluebird bio (BLUE) in Q3 2024, closing a stake of 51,869 shares — an estimated $1.02M sold.

Bleichroeder LP first reported a position in BLUE in Q2 2020 and held it in 7 quarters. The position peaked at $3.45M in Q4 2023. 140 funds tracked by Wall St. Rank hold BLUE as of Q3 2024.

  • Bleichroeder LP reported no remaining bluebird bio position as of Q3 2024 after selling out during the quarter.
  • Bleichroeder LP sold 51,869 bluebird bio shares in Q3 2024, an estimated $1.02M.
  • Bleichroeder LP first reported a position in bluebird bio in Q2 2020 and held it in 7 quarters.
  • Bleichroeder LP's bluebird bio position peaked at $3.45M in Q4 2023.
  • 140 funds tracked by Wall St. Rank held bluebird bio as of Q3 2024.

Based on Bleichroeder LP's 13F filing for Q3 2024, filed 13 Nov 2024.